Cosmos Holdings, Inc. Announces $3 Million Securities Purchase Agreement With Two Institutional Investors

CHICAGO, IL--(Marketwired - Nov 16, 2017) - Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that it has entered into a $3 million securities purchase agreement with two institutional investors.

"We are excited to announce the addition of two institutional investors," said Grigorios Siokas, President and CEO of Cosmos Holdings. "This agreement will provide us with capital to continue to grow our operations and expand our business."

The securities sold have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements. This release is not used for the purpose of conditioning the market in the United States for any of the securities offered.

About Cosmos Holdings, Inc.

Cosmos Holdings Inc. is a pharmaceutical company focused on identifying, acquiring, developing, and commercializing medicines to improve patients' lives and outcomes. The Company has a trans-European network of over 110 clients and vendors expands to 16 countries including: Germany, United Kingdom, Ireland, United Arab Emirates, Denmark, Italy, France, Singapore, Spain, Lebanon, Skopje, Jordan, Sweden, Poland, Netherlands, and AN or circumstances occurring after the date hereof or the occurrence of unanticipated events or for any changes or modifications made to this press release or the information contained herein by any third-parties, including, but not limited to, any wire or internet services.

A more complete and detailed description of the Purchase Agreement and Registration Rights Agreement is set forth Form 8-K filed November 16, 2017 with the SEC.


Except for historical information, this news release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements involve unknown risks, and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. Important factors that might cause such differences are discussed in the Company's filings with the Securities and Exchange Commission. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Actual results could differ materially from those anticipated in these forward-looking statements, if new information becomes available in the future.

Contact Information:

For More Information, Contact:
Steve Carr
Managing Director
Dresner Corporate Services

Integra Consulting Group LLC
Jeremy Roe
Managing Partner
+1 925 262 8305